Advisory Council for the Elimination of Tuberculosis Meeting (ACET), 66382 [2014-26509]

Download as PDF 66382 Federal Register / Vol. 79, No. 216 / Friday, November 7, 2014 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondents Form name Public School Officials ...................... Public School Officials ...................... Public School Officials ...................... Recruitment Call to Superintendent Office Script ........ Recruitment Call to Respondent Script ........................ Discussion Guide .......................................................... Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2014–26473 Filed 11–6–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Council for the Elimination of Tuberculosis Meeting (ACET) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: mstockstill on DSK4VPTVN1PROD with NOTICES Times and Dates 8:30 a.m.–5:00 p.m., December 2, 2014 8:30 a.m.–2:30 p.m., December 3, 2014 Place: Corporate Square, Corporate Boulevard, Building 8, 1st Floor Conference Room, Atlanta, Georgia 30329, telephone (404) 639–8317. This meeting is also accessible by Webinar. For Participants URL: https://www.mymeetings.com/nc/ join/. Conference number: PW8649920. Audience passcode: 4223129. Participants can join the event directly at: https://www.mymeetings.com/nc/join.php?i= PW8649920&p=4223129&t=c. USA Toll-free +1 (800) 857–9615, Participant code: 4223129. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 100 people. Purpose: This Council advises and makes recommendations to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis. Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; and reviews the extent to which progress has been made toward eliminating tuberculosis. Matters for Discussion: Agenda items include the following topics: (1) Drug Shortages—Non-U.S. based drug VerDate Sep<11>2014 19:12 Nov 06, 2014 Jkt 235001 manufactures and Food and Drug Administration (FDA) approval and FDA’s role in addressing drug shortages; (2) TB elimination—Stop TB Elimination Plan Update and the Perspectives from National Tuberculosis Controllers Association (NTCA) and the Nation’s TB Control Programs; (3) Updates from Workgroups; and (4) other tuberculosis-related issues. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Margie Scott-Cseh, Centers for Disease Control and Prevention, 1600 Clifton Road NE., M/S E–07, Atlanta, Georgia 30333, telephone (404) 639–8317. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–26509 Filed 11–6–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Injury Prevention and Control (BSC, NCIPC) In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces, the following meeting of the aforementioned committee: Time and Date: 9:00 a.m.–12:00 p.m., December 9, 2014 (OPEN). Place: Teleconference. Status: The meeting is open to the public; the toll free dial in number is 1–877–937– 9818 with a pass code of 751384. Purpose: The board makes recommendations regarding policies, strategies, objectives, and priorities, and reviews progress toward injury prevention goals and provides evidence in injury prevention-related research and programs. The board provides advice on the appropriate balance of intramural and extramural PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 Number of responses per respondent 84 84 28 1 1 1 Average burden per response (in hours) 7/60 7/60 30/60 research, and provides advice on the structure, progress and performance of intramural programs. The Board of Scientific Counselors is also designed to provide guidance on extramural scientific program matters, including the: (1) Review of extramural research concepts for funding opportunity announcements; (2) conduct of Secondary Peer Review of extramural research grants, cooperative agreements, and contracts applications received in response to the funding opportunity announcements as it relates to the Center’s programmatic balance and mission; (3) submission of secondary review recommendations to the Center Director of applications to be considered for funding support; (4) review of research portfolios, and (5) review of program proposals. The board shall provide guidance on the National Center of Injury Prevention and Control’s programs and research activities by conducting scientific peer review of intramural research and programs within the National Center for Injury Prevention and Control; by ensuring adherence to Office of Management and Budget requirements for intramural peer review; and by monitoring the overall direction, focus, and success of the National Center for Injury Prevention and Control. Matters for Discussion: The BSC, NCIPC will provide guidance on current research areas; as well as, receive an update from the current NCIPC Portfolio Review Workgroup on the Web-based Injury Surveillance Query and Reporting System (WISQARS) and the BSC Workgroup on Mild Pediatric Traumatic Brain Injury Guidelines. In addition, the BSC will discuss research strategies needed to guide the Center’s focus and discuss potential topics for the upcoming Portfolio Review. There will be 15 minutes allotted for public comments at the end of the open session. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Dr. Gwendolyn H. Cattledge, Ph.D., M.S.E.H., Designated Federal Official, NCIPC, CDC, 4770 Buford Highway NE., Mailstop F–63, Atlanta, Georgia 30341, Telephone (770) 488–1430. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and E:\FR\FM\07NON1.SGM 07NON1

Agencies

[Federal Register Volume 79, Number 216 (Friday, November 7, 2014)]
[Notices]
[Page 66382]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-26509]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Council for the Elimination of Tuberculosis Meeting 
(ACET)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:

Times and Dates

8:30 a.m.-5:00 p.m., December 2, 2014
8:30 a.m.-2:30 p.m., December 3, 2014

    Place: Corporate Square, Corporate Boulevard, Building 8, 1st 
Floor Conference Room, Atlanta, Georgia 30329, telephone (404) 639-
8317. This meeting is also accessible by Webinar.

For Participants

    URL: https://www.mymeetings.com/nc/join/.
    Conference number: PW8649920.
    Audience passcode: 4223129.
    Participants can join the event directly at: https://www.mymeetings.com/nc/join.php?i=PW8649920&p=4223129&t=c.
    USA Toll-free +1 (800) 857-9615, Participant code: 4223129.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 100 people.
    Purpose: This Council advises and makes recommendations to the 
Secretary of Health and Human Services, the Assistant Secretary for 
Health, and the Director, CDC, regarding the elimination of 
tuberculosis. Specifically, the Council makes recommendations 
regarding policies, strategies, objectives, and priorities; 
addresses the development and application of new technologies; and 
reviews the extent to which progress has been made toward 
eliminating tuberculosis.
    Matters for Discussion: Agenda items include the following 
topics: (1) Drug Shortages--Non-U.S. based drug manufactures and 
Food and Drug Administration (FDA) approval and FDA's role in 
addressing drug shortages; (2) TB elimination--Stop TB Elimination 
Plan Update and the Perspectives from National Tuberculosis 
Controllers Association (NTCA) and the Nation's TB Control Programs; 
(3) Updates from Workgroups; and (4) other tuberculosis-related 
issues. Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Margie Scott-Cseh, Centers 
for Disease Control and Prevention, 1600 Clifton Road NE., M/S E-07, 
Atlanta, Georgia 30333, telephone (404) 639-8317.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2014-26509 Filed 11-6-14; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.